XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

Takeda regains a majority of XOMA Royalty’s royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a ...

XOMA Royalty Corporation: XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab

Takeda regains a majority of XOMA Royalty's royalty interest in mezagitamab (TAK-079) -- XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine ...
AgWeb

Phosphate Fertilizer Prices Soar Near Historic Highs

Looking at 20 years of data from Stone X shows how 2025 and 2008 have elevated levels in phosphate pricing relative to corn price. One time spot pricing in New Orleans broke the historic high, however ...
eLife

Translational reading frame determines the pathogenicity of C-terminal frameshift deletions in MeCP2: an alternative therapeutic approach

This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Metal

Latest Update in the SMM Phosphorus Market

Stable Prices for Phosphate Fertilizers Expected as Spring Plowing Approaches; Will High-Cost Phosphorus Chemical Products Shift to the New Energy Sector?